日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition)

经尿道等离子体动力前列腺切除术治疗良性前列腺增生的临床实践指南(2021版)

Zeng, Xian-Tao; Jin, Ying-Hui; Liu, Tong-Zu; Chen, Fang-Ming; Ding, De-Gang; Fu, Meng; Gu, Xin-Quan; Han, Bang-Min; Huang, Xing; Hou, Zhi; Hu, Wan-Li; Kang, Xin-Li; Li, Gong-Hui; Li, Jian-Xing; Li, Pei-Jun; Liang, Chao-Zhao; Liu, Xiu-Heng; Liu, Zhi-Yu; Liu, Chun-Xiao; Liu, Jiu-Min; Luo, Guang-Heng; Luo, Yi; Qin, Wei-Jun; Qiu, Jian-Hong; Qiu, Jian-Xin; Shang, Xue-Jun; Shi, Ben-Kang; Sun, Fa; Tian, Guo-Xiang; Tian, Ye; Wang, Feng; Wang, Feng; Wang, Yin-Huai; Wang, Yu-Jie; Wang, Zhi-Ping; Wang, Zhong; Wei, Qiang; Xiao, Min-Hui; Xu, Wan-Hai; Yi, Fa-Xian; Zhu, Chao-Yang; Zhuang, Qian-Yuan; Zhou, Li-Qun; Zou, Xiao-Feng; Xing, Nian-Zeng; He, Da-Lin; Wang, Xing-Huan

The collaboration between infectious disease modeling and public health decision-making based on the COVID-19

基于 COVID-19 的传染病建模与公共卫生决策之间的合作

Niu, Yan; Li, Zhuoyang; Meng, Ling; Wang, Shengnan; Zhao, Zeyu; Song, Tie; Lu, Jianhua; Chen, Tianmu; Li, Qun; Zou, Xuan

Survivin is a prognostic marker and therapeutic target for extranodal, nasal-type natural killer/T cell lymphoma

Survivin 是结外鼻型自然杀伤/T 细胞淋巴瘤的预后标志物和治疗靶点

Li Zhang, Yi Wei, Xiaowei Yan, Na Li, Haolan Song, Li Yang, Yang Wu, Yu-Feng Xi, Hua-Wei Weng, Jian-Hua Li, Edward H Lin, Li-Qun Zou

Serum B-cell activating factor predicts prognosis in nasal type, extranodal NK/T cell lymphoma

血清 B 细胞活化因子可预测鼻型、结外 NK/T 细胞淋巴瘤的预后

Li Zhang, Na Li, Li Yang, Jing Zhang, Hua-Wei Weng, Li-Qun Zou